MABE354 Sigma-AldrichAnti-Uracil-DNA glycosylase Antibody, clone 8G10.1
Anti-Uracil-DNA glycosylase Antibody, clone 8G10.1, Cat. No. MABE354, is a highly specific mouse monoclonal antibody, that targets UNG and has been tested in Western Blotting and Immunohistochemistry.
More>> Anti-Uracil-DNA glycosylase Antibody, clone 8G10.1, Cat. No. MABE354, is a highly specific mouse monoclonal antibody, that targets UNG and has been tested in Western Blotting and Immunohistochemistry. Less<<Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| H | WB, IHC | M | Purified | Monoclonal Antibody |
| References |
|---|
| Product Information | |
|---|---|
| Format | Purified |
| Presentation | Purified mouse monoclonal IgG2aκ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. |
| Quality Level | MQ100 |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Storage and Shipping Information | |
|---|---|
| Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
| Packaging Information | |
|---|---|
| Material Size | 100 μg |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| MABE354 | 04055977176902 |
Documentation
Anti-Uracil-DNA glycosylase Antibody, clone 8G10.1 SDS
| Title |
|---|
Anti-Uracil-DNA glycosylase Antibody, clone 8G10.1 Certificates of Analysis
| Title | Lot Number |
|---|---|
| Anti-Uracil-DNA glycosylase, -Q2583339 | Q2583339 |
| Anti-Uracil-DNA glycosylase, clone 8G10.1 - 3587089 | 3587089 |
Technical Info
| Title |
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
| White Paper: Further considerations of antibody validation and usage. |



